A nurse is talking with a client who has a new prescription for an ipratropium inhaler to treat exercise-induced bronchospasm. Which of the following client statements should the nurse report to the provider?

Choice A rationale Ipratropium is an anticholinergic medication that works by blocking muscarinic receptors in the smooth muscles of the bronchi, leading to bronchodilation. It does not directly affect the cardiovascular system in a way that would significantly worsen hypertension, particularly in its inhaled form where systemic absorption is minimal. Therefore, this statement does not require immediate reporting to the provider. Choice B rationale It is appropriate and necessary for the client to continue using their albuterol as needed for acute bronchospasm. Ipratropium is a long-acting bronchodilator used for maintenance therapy, not for rapid relief of symptoms. The client should be instructed to use albuterol, a short-acting beta-2 agonist, as their rescue inhaler to manage sudden episodes of shortness of breath. Choice C rationale Ipratropium is a derivative of atropine and shares a similar chemical structure and mechanism of action. An allergy to atropine indicates a potential hypersensitivity to anticholinergic agents, including ipratropium. Administering ipratropium to a client with an atropine allergy could trigger a severe allergic reaction, such as anaphylaxis. This statement is a critical safety concern and must be reported immediately. Choice D rationale Moderate alcohol consumption, such as a single glass of red wine, is generally not contraindicated with ipratropium. While some medications can have adverse interactions with alcohol, there is no significant interaction documented between ipratropium and moderate alcohol intake that would necessitate reporting to the provider. The client can likely continue their normal routine.